PATENT CLAIM ANALYSIS

Application Number: 15921651
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-09
Patent Classification: ["424", "465000"]

Abstract:
The present invention provides modified release pharmaceutical compositions, and methods for administering the compositions to a user, including humans. The composition may contain a combination of ingredients in proportions calculated to achieve therapeutic effect, including at least the following ingredients: one or more natural or synthetic cannabinoids, one or more release modifying agent(s), and one or more pharmaceutically acceptable excipient(s). The composition may be in a multi-layered solid dosage form to provide fast, controlled and also sustained release of specific ingredients. More specifically, the invention relates to modified release pharmaceutical compositions comprising cannabinoids and a process for preparation thereof. More specifically, the invention may control drug release in accordance with the therapeutic purpose and pharmacological properties of active substances.

Claim (Index 10):
The drug composition of  claim 6  wherein at least one layer of the multi-layer tablet comprises an active ingredient other than a cannabinoid.

Metadata:
- Claim Count in Document: 11.0
- Percentile: 90.0
- Lexical Diversity: 1.80519
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['10505122', '15789998', '10505136', '10243059', '10468041']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7690491998698507
- 35 USC 102 Novelty (BERT): 0.5260366718651474
- Combined Prediction Score: 0.7447479470693804
- Mean Citation Score: 306.408282
- Max Citation Score: 326.0809
- Similarity Product: 200.1342841084837

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test